American Eagle’s Partnership with CBD Producer Spurns Complaints from Concerned Parents
The wildly popular cannabinoid is creating lucrative opportunities for investors, but still maintains a dubious status with the Food & Drug Administration.
MORE STORIES LIKE THIS
Featured Franchise News
Featured Brand News